1 / 70

MYOCARDIAL INFARCTION AND ACUTE CORONARY SYNDROME

CHART LIBRARY POWERPOINT TOOL The best way to find out what information a particular CHART library can give you, is to take a look at the summary sheet. To do this, simply click on one of the libraries below. MYOCARDIAL INFARCTION AND ACUTE CORONARY SYNDROME. SAFER PRESCRIBING.

zhen
Download Presentation

MYOCARDIAL INFARCTION AND ACUTE CORONARY SYNDROME

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CHART LIBRARY POWERPOINT TOOLThe best way to find out what information a particular CHART library can give you, is to take a look at the summary sheet. To do this, simply click on one of the libraries below. MYOCARDIAL INFARCTIONAND ACUTE CORONARYSYNDROME SAFER PRESCRIBING GRASP AF(ATRIAL FIBRILLATION) HEROIN MISUSE MMR VACCINATION PNEUMOCOCCALVACCINATION LOCAL DELIVERY PLAN(SMOKING & OBESITY) IM&T DES SPARE BUTTON AWAITINGFOR ANY NEW LIBRARY SUMMARY, CHARTS, DATASHEET EXAMPLE CHARTONLINE CHART & MIQUEST OVERVIEW

  2. HOW CHART & MIQUEST WORK Click the mouse to see the CHART process step by step BACK TO MENU

  3. HOW CHART & MIQUEST WORK Click the mouse to see the CHART process step by step PRIMIS+ WEBSITE CLINICAL SYSTEM CHART SOFTWARE MIACS Queries ondisk/pen drive/network CHART QUERY LIBRARIESSAFER PRESCRIBING, FLU, SWINE FLU, MIACS, MMRHEROIN MISUSE, LDP MIQUESTINTERPRETER CLINICALSYSTEMDATABASE PRACTICE COMPUTER CHART SOFTWARE LIBRARIESSWINE FLU MIACS MIACS SUMMARY SHEET MIACS DATA SHEET MIACS GRAPHS MIACS Responses on disk/pen drive/network BACK TO MENU

  4. CHART LIBRARIESThe best way to find out what information a particular CHART library can give you, is to take a look at the summary sheet. To do this, simply click on one of the libraries below. MYOCARDIAL INFARCTIONAND ACUTE CORONARYSYNDROME SAFER PRESCRIBING GRASP AF(ATRIAL FIBRILLATION) HEROIN MISUSE MMR VACCINATION PNEUMOCOCCALVACCINATION LOCAL DELIVERY PLAN(SMOKING & OBESITY) IM&T DES SPARE BUTTON AWAITINGFOR ANY NEW LIBRARY SUMMARY, CHARTS, DATASHEET EXAMPLE CHARTONLINE CHART & MIQUEST OVERVIEW

  5. 1 PRIMIS+ WEBSITE CHART SOFTWARECHART QUERY LIBRARIES MIQUESTINTERPRETER 2 3 3 4 5 PRACTICE COMPUTER CHART SOFTWARECHART QUERY LIBRARIES CLINICALSYSTEMDATABASE PRACTICE COMPUTERSUMMARY SHEETDATA SHEETGRAPHS HOW CHART & MIQUEST WORK 1) Download CHART Software and CHART Query Libraries free from PRIMIS+ Website and install on Practice Computer – (One off process) 2) Create CHART MIQUEST Queries and load them into MIQUEST Interpreter on Clinical System 3) MIQUEST Interpreter interrogates Clinical System Database 4) Obtain CHART MIQUEST Responses from MIQUEST Interpreter on Clinical System 5) Load CHART MIQUEST RESPONSES into CHART Software and see SUMMARY SHEET, DATA SHEET and GRAPHS Queries on disk/pen drive/network Responses on disk/pen drive/network BACK TO MENU

  6. MI & ACS CHOOSE ANOTHER LIBRARY MI & ACS HOME POPULATION ADVICE & PROCEDURES MEDICATION HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY The NICE MIACS guidance covers such things as dietary advice, exercise advice,referral to cardiac rehabilitation, smoking advice and the use of specific drugs. One area that many PCTs may also have an interest in is the appropriate use of Clopidogrel, an expensive drug used for varying lengths of time after an infarct. The audit will enable practices to see that they are using it in accordance with the guidance. To take a look at a particular area, please click the appropriate button above. Population Advice & Procedures Medication Heart Failure Clopidogrel MI by Category ACS by Category

  7. MI & ACS CHOOSE ANOTHER LIBRARY MI & ACS HOME POPULATION ADVICE & PROCEDURES MEDICATION HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY

  8. MI & ACS CHOOSE ANOTHER LIBRARY MI & ACS HOME POPULATION ADVICE & PROCEDURES MEDICATION HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY

  9. MI & ACS CHOOSE ANOTHER LIBRARY MI & ACS HOME POPULATION ADVICE & PROCEDURES MEDICATION HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY

  10. MI & ACS CHOOSE ANOTHER LIBRARY MI & ACS HOME POPULATION ADVICE & PROCEDURES MEDICATION HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY

  11. It is not useful for these patients so we are wasting resource by giving it to them. MI & ACS CHOOSE ANOTHER LIBRARY MI & ACS HOME POPULATION ADVICE & PROCEDURES MEDICATION HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY EXPLANATION Clopidogrel is an expensive drug. It is beneficial for patients in categories 1 to 3. It is not beneficial for patients in categories 5 to 9. Because the type of MI is unspecified, we do not know whether it will be beneficial for patients in category 4. Therefore the patients represented by red numbers should be on clopidogrel and are not. The patients represented by blue numbers are on clopidogrel even though it is of no benefit to them. The patients represented by green numbers need investigating further before we know whether their clopidogrel status is correct.

  12. MI & ACS CHOOSE ANOTHER LIBRARY MI & ACS HOME POPULATION ADVICE & PROCEDURES MEDICATION HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY EXPLANATION To treat an MI correctly, you need to know what type of MI it is. The patients represented by red numbers , particularly hose with an MI in the last 12 months, would need to have a more specific diagnosis put on their medical record.

  13. MI & ACS CHOOSE ANOTHER LIBRARY MI & ACS HOME POPULATION ADVICE & PROCEDURES MEDICATION HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY

  14. HEROIN MISUSE CHOOSE ANOTHER LIBRARY HEROIN MISUSE HOME MISUSE BY AGE THERAPY ENGAGEMENT HEPATITIS & HIV OTHER INFORMATION The Heroin Misuse Summary sheet is a collection of tables showing useful information about patients who have misused heroin. To take a look at a table, please click the appropriate button above. Misuse by Age Therapy Engagement Hepatitis & HIV Other Information

  15. HEROIN MISUSE CHOOSE ANOTHER LIBRARY HEROIN MISUSE HOME MISUSE BY AGE THERAPY ENGAGEMENT HEPATITIS & HIV OTHER INFORMATION

  16. HEROIN MISUSE CHOOSE ANOTHER LIBRARY HEROIN MISUSE HOME MISUSE BY AGE THERAPY ENGAGEMENT HEPATITIS & HIV OTHER INFORMATION

  17. HEROIN MISUSE CHOOSE ANOTHER LIBRARY HEROIN MISUSE HOME MISUSE BY AGE THERAPY ENGAGEMENT HEPATITIS & HIV OTHER INFORMATION

  18. HEROIN MISUSE CHOOSE ANOTHER LIBRARY HEROIN MISUSE HOME MISUSE BY AGE THERAPY ENGAGEMENT HEPATITIS & HIV OTHER INFORMATION

  19. LDP – LOCAL DELIVERY PLAN CHOOSE ANOTHER LIBRARY LDP HOME SMOKING OBESITY The aim of the Local Delivery Plan analysis package for Smoking and Obesity is to enable practices to extract, process and send the required data specified by the Department of Health to your PCT. The data is broken down into tables that show the practice population, and the age/sex of all patients with a BMI and Smoking Status Smoking Obesity

  20. LDP – LOCAL DELIVERY PLAN CHOOSE ANOTHER LIBRARY LDP HOME SMOKING OBESITY

  21. LDP – LOCAL DELIVERY PLAN CHOOSE ANOTHER LIBRARY LDP HOME SMOKING OBESITY

  22. SAFER PRESCRIBING CHOOSE ANOTHER LIBRARY SAFER PRESCRIBING HOME POSSIBLE INAPPROPRIATE PRESCRIBING POSSIBLE INADEQUATE MONITORING – PART 1 POSSIBLE INADEQUATE MONITORING – PART 2 POSSIBLE INAPPROPRIATEDRUG FOR AGE POSSIBLE OVERLOOKEDSAFETY INFORMATION POSSIBLE OVERLOOKED LABORATORY TESTS The Safer Prescribing Library allows practices to examine their current prescribing to identify issues or even systems which might need attention. To take a look at some of the summary sheets available, please click the appropriate button above.

  23. SAFER PRESCRIBING CHOOSE ANOTHER LIBRARY SAFER PRESCRIBING HOME POSSIBLE INAPPROPRIATE PRESCRIBING POSSIBLE INADEQUATE MONITORING – PART 1 POSSIBLE INADEQUATE MONITORING – PART 2 POSSIBLE INAPPROPRIATEDRUG FOR AGE POSSIBLE OVERLOOKEDSAFETY INFORMATION POSSIBLE OVERLOOKED LABORATORY TESTS

  24. SAFER PRESCRIBING CHOOSE ANOTHER LIBRARY SAFER PRESCRIBING HOME POSSIBLE INAPPROPRIATE PRESCRIBING POSSIBLE INADEQUATE MONITORING – PART 1 POSSIBLE INADEQUATE MONITORING – PART 2 POSSIBLE INAPPROPRIATEDRUG FOR AGE POSSIBLE OVERLOOKEDSAFETY INFORMATION POSSIBLE OVERLOOKED LABORATORY TESTS

  25. SAFER PRESCRIBING CHOOSE ANOTHER LIBRARY SAFER PRESCRIBING HOME POSSIBLE INAPPROPRIATE PRESCRIBING POSSIBLE INADEQUATE MONITORING – PART 1 POSSIBLE INADEQUATE MONITORING – PART 2 POSSIBLE INAPPROPRIATEDRUG FOR AGE POSSIBLE OVERLOOKEDSAFETY INFORMATION POSSIBLE OVERLOOKED LABORATORY TESTS

  26. SAFER PRESCRIBING CHOOSE ANOTHER LIBRARY SAFER PRESCRIBING HOME POSSIBLE INAPPROPRIATE PRESCRIBING POSSIBLE INADEQUATE MONITORING – PART 1 POSSIBLE INADEQUATE MONITORING – PART 2 POSSIBLE INAPPROPRIATEDRUG FOR AGE POSSIBLE OVERLOOKEDSAFETY INFORMATION POSSIBLE OVERLOOKED LABORATORY TESTS

  27. SAFER PRESCRIBING CHOOSE ANOTHER LIBRARY SAFER PRESCRIBING HOME POSSIBLE INAPPROPRIATE PRESCRIBING POSSIBLE INADEQUATE MONITORING – PART 1 POSSIBLE INADEQUATE MONITORING – PART 2 POSSIBLE INAPPROPRIATEDRUG FOR AGE POSSIBLE OVERLOOKEDSAFETY INFORMATION POSSIBLE OVERLOOKED LABORATORY TESTS

  28. SAFER PRESCRIBING CHOOSE ANOTHER LIBRARY SAFER PRESCRIBING HOME POSSIBLE INAPPROPRIATE PRESCRIBING POSSIBLE INADEQUATE MONITORING – PART 1 POSSIBLE INADEQUATE MONITORING – PART 2 POSSIBLE INAPPROPRIATEDRUG FOR AGE POSSIBLE OVERLOOKEDSAFETY INFORMATION POSSIBLE OVERLOOKED LABORATORY TESTS

  29. GRASP AF – (ATRIAL FIBRILLATION) CHOOSE ANOTHER LIBRARY ATRIAL FIBRILLATION HOME ATRIAL FIBRILLATION& CHADS SCORE WARFARIN What does GRASP-AF do? Provides a set of MIQUEST queries to identify, for your practice, patients with a diagnosis of AF who are not on warfarin The GRASP - AF tool will calculate their stroke risk using the validated CHADS2 scoring system. The tool will highlight patients with a CHADS2 score of 2 or more not receiving warfarin who would benefit from review to assess the issue of anti-coagulation. The tool does not assess contraindications to warfarin, the decision whether or not to start warfarin remains a clinical one. Click on the buttons above to see the information that is available on the CHART summary sheets. AF & CHADS Score Warfarin

  30. GRASP AF – (ATRIAL FIBRILLATION) CHOOSE ANOTHER LIBRARY ATRIAL FIBRILLATION HOME ATRIAL FIBRILLATION& CHADS SCORE WARFARIN

  31. GRASP AF – (ATRIAL FIBRILLATION) CHOOSE ANOTHER LIBRARY ATRIAL FIBRILLATION HOME ATRIAL FIBRILLATION& CHADS SCORE WARFARIN

  32. MMR CATCHUP CAMPAIGN CHOOSE ANOTHER LIBRARY MMR HOME MMR SUMMARYSHEET The MMR CHART library has been designed to enable practices to identify patients that fall into the first three priority age groups specified in the Chief Medical Officer MMR Catch-Up Programme letter dated 6th August 2008. The library identifies patients under the age of nineteen that have had zero, one, or two MMR vaccinations to enable practices to review patient details for recall.

  33. MMR CATCHUP CAMPAIGN CHOOSE ANOTHER LIBRARY MMR HOME MMR SUMMARYSHEET

  34. IM&T DES CHOOSE ANOTHER LIBRARY IM&T DES HOME DRUGS TO DISEASEAUDITS ALLERGYAUDIT CHOLECYSTECTOMYAUDIT HYSTERECTOMYAUDIT WRONG SEX AUDIT REFERRALS, LOCATION,SUMMARY AUDIT TOP LEVEL CODESAUDIT The PRIMIS+ IM&T DES CHART Library was designed to help practices to achieve accredited data quality standards so that their information is fit for sharing in the NHS Care Records Service. This is a key objective of the IM&T DES. To see the summary sheets from some of the IM&T DES Queries, please click on the buttons above.

  35. IM&T DES – DRUGS TO DIAGNOSIS AUDITS IMT DES HOME DRUGS TO DIAGNOSISHOME DRUGS TO DIAGNOSISAUDIT 1 DRUGS TO DIAGNOSISAUDIT 2 DRUGS TO DIAGNOSISAUDIT 3 DRUGS TO DIAGNOSISAUDIT 4 DRUGS TO DIAGNOSISAUDIT 5 DRUGS TO DIAGNOSISAUDIT 6

  36. IM&T DES – DRUGS TO DIAGNOSIS AUDITS IMT DES HOME DRUGS TO DIAGNOSISHOME DRUGS TO DIAGNOSISAUDIT 1 DRUGS TO DIAGNOSISAUDIT 2 DRUGS TO DIAGNOSISAUDIT 3 DRUGS TO DIAGNOSISAUDIT 4 DRUGS TO DIAGNOSISAUDIT 5 DRUGS TO DIAGNOSISAUDIT 6

  37. IM&T DES – DRUGS TO DIAGNOSIS AUDITS IMT DES HOME DRUGS TO DIAGNOSISHOME DRUGS TO DIAGNOSISAUDIT 1 DRUGS TO DIAGNOSISAUDIT 2 DRUGS TO DIAGNOSISAUDIT 3 DRUGS TO DIAGNOSISAUDIT 4 DRUGS TO DIAGNOSISAUDIT 5 DRUGS TO DIAGNOSISAUDIT 6

  38. IM&T DES – DRUGS TO DIAGNOSIS AUDITS IMT DES HOME DRUGS TO DIAGNOSISHOME DRUGS TO DIAGNOSISAUDIT 1 DRUGS TO DIAGNOSISAUDIT 2 DRUGS TO DIAGNOSISAUDIT 3 DRUGS TO DIAGNOSISAUDIT 4 DRUGS TO DIAGNOSISAUDIT 5 DRUGS TO DIAGNOSISAUDIT 6

  39. IM&T DES – DRUGS TO DIAGNOSIS AUDITS IMT DES HOME DRUGS TO DIAGNOSISHOME DRUGS TO DIAGNOSISAUDIT 1 DRUGS TO DIAGNOSISAUDIT 2 DRUGS TO DIAGNOSISAUDIT 3 DRUGS TO DIAGNOSISAUDIT 4 DRUGS TO DIAGNOSISAUDIT 5 DRUGS TO DIAGNOSISAUDIT 6

  40. IM&T DES – DRUGS TO DIAGNOSIS AUDITS IMT DES HOME DRUGS TO DIAGNOSISHOME DRUGS TO DIAGNOSISAUDIT 1 DRUGS TO DIAGNOSISAUDIT 2 DRUGS TO DIAGNOSISAUDIT 3 DRUGS TO DIAGNOSISAUDIT 4 DRUGS TO DIAGNOSISAUDIT 5 DRUGS TO DIAGNOSISAUDIT 6

  41. IM&T DES – DRUGS TO DIAGNOSIS AUDITS IMT DES HOME DRUGS TO DIAGNOSISHOME DRUGS TO DIAGNOSISAUDIT 1 DRUGS TO DIAGNOSISAUDIT 2 DRUGS TO DIAGNOSISAUDIT 3 DRUGS TO DIAGNOSISAUDIT 4 DRUGS TO DIAGNOSISAUDIT 5 DRUGS TO DIAGNOSISAUDIT 6

  42. IM&T DES ALLERGY AUDIT IMT DES HOME ALLERGY AUDIT HOME NON DRUGALLERGY AUDIT DRUGALLERGY AUDIT NON Drug Allergy Drug Allergy

  43. IM&T DES ALLERGY AUDIT IMT DES HOME ALLERGY AUDIT HOME NON DRUGALLERGY AUDIT DRUGALLERGY AUDIT

  44. IM&T DES ALLERGY AUDIT IMT DES HOME ALLERGY AUDIT HOME NON DRUGALLERGY AUDIT DRUGALLERGY AUDIT

  45. IM&T DES CHOLECYSTECTOMY AUDIT CHOOSE ANOTHER LIBRARY IM&T DES HOME DRUGS TO DISEASEAUDITS ALLERGYAUDIT CHOLECYSTECTOMYAUDIT HYSTERECTOMYAUDIT WRONG SEX AUDIT REFERRALS, LOCATION,SUMMARY AUDIT TOP LEVEL CODESAUDIT

  46. IM&T DES HYSTERECTOMY AUDIT CHOOSE ANOTHER LIBRARY IM&T DES HOME DRUGS TO DISEASEAUDITS ALLERGYAUDIT CHOLECYSTECTOMYAUDIT HYSTERECTOMYAUDIT WRONG SEX AUDIT REFERRALS, LOCATION,SUMMARY AUDIT TOP LEVEL CODESAUDIT

  47. IM&T DES WRONG SEX AUDIT IMT DES HOME WRONG SEX AUDIT HOME FEMALE CODESIN MALE RECORDS MALE CODES IN FEMALE RECORDS Female Codes In Male Records Male Codes In Female Records

  48. IM&T DES WRONG SEX AUDIT IMT DES HOME WRONG SEX AUDIT HOME FEMALE CODESIN MALE RECORDS MALE CODES IN FEMALE RECORDS

  49. IM&T DES WRONG SEX AUDIT IMT DES HOME WRONG SEX AUDIT HOME FEMALE CODESIN MALE RECORDS MALE CODES IN FEMALE RECORDS

  50. IM&T DES REFERRALS & LOCATIONS & SUMMARIES AUDIT IMT DES HOME REFERRALS, LOCATION,SUMMARY HOME REFERRALS LOCATIONS SUMMARIES Referrals Locations Summaries

More Related